OCUL CIK: 1393434

Ocular Therapeutix, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.19
FY22:
0.13
FY23:
0.23
FY24:
0.44
FY25:
0.78
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.02
FY23:
0.02
FY24:
0.02
FY25:
0.03
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.20
FY22:
0.15
FY23:
0.25
FY24:
0.46
FY25:
0.81

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.03
FY22:
0.03
FY23:
0.03
FY24:
0.04
FY25:
0.05
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.08
FY23:
0.13
FY24:
0.10
FY25:
0.10
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.04
FY23:
0.09
FY24:
0.32
FY25:
0.65
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.20
FY22:
0.15
FY23:
0.25
FY24:
0.46
FY25:
0.81

All amounts in billions USD Data source:SEC EDGAR